SCHEMBL6320277

SCHEMBL6320277

OCC1CC2CC1C1CCCC21

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.40
CA12 O43570 2/20 0.40
GMNN O75496 2/20 0.40
ALDH1A1 P00352 2/20 0.40
CA1 P00915 2/20 0.40
CA2 P00918 2/20 0.40
LMNA P02545 2/20 0.40
BLM P54132 2/20 0.40
CA9 Q16790 2/20 0.40
TDP1 Q9NUW8 2/20 0.40
SGMS1 Q86VZ5 1/20 0.40
SGMS2 Q8NHU3 1/20 0.40
KDM4E B2RXH2 1/20 0.39
MEN1 O00255 1/20 0.39
TP53 P04637 1/20 0.39
CYP3A4 P08684 1/20 0.39
CYP2C9 P11712 1/20 0.39
ALOX15 P16050 1/20 0.39
TSHR P16473 1/20 0.39
ALOX12 P18054 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14890320 0.83 MAPT (0.38) MAPTCA12GMNNALDH1A1CA1
SCHEMBL7081831 0.83 CYP1A2 (0.37) MAPTCA12GMNNALDH1A1CA1
Ammonia Solution, Strong SCHEMBL6014569 0.78
SCHEMBL11408408 0.77 MAPT (0.36) MAPTCA12GMNNALDH1A1CA1
SCHEMBL12414534 0.77 MAPT (0.36) MAPTCA12GMNNALDH1A1CA1
SCHEMBL11404959 0.77 MAPT (0.36) MAPTCA12GMNNALDH1A1CA1
SCHEMBL13188778 0.77 MAPT (0.41) MAPTCA12GMNNALDH1A1CA1
SCHEMBL14593466 0.75 CYP1A2 (0.49) MAPTCA12GMNNALDH1A1CA1
SCHEMBL6257822 0.74 CHRM1 (0.35) TDP1CHRM1
SCHEMBL14890141 0.74 MAPT (0.35) MAPTCA12GMNNALDH1A1CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 92 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4709586-A1 ACTINICALLY-CURABLE COMPOSITIONS HAVING HIGH DIMENSIONAL ACCURACY ARKEMA France (FR) 2026-03-18 EP claimed
US-20250297128-A1 ACRYLIC POLYESTER RESIN AND AN AQUEOUS OR POWDER COATING COMPOSITION CONTAINING THE SAME PPG INDUSTRIES OHIO, INC. 2025-09-25 US claimed
US-20250188308-A1 ACRYLIC POLYESTER RESIN AND AN AQUEOUS OR POWDER COATING COMPOSITION CONTAINING THE SAME PPG INDUSTRIES OHIO, INC. 2025-06-12 US claimed
US-12258485-B2 Acrylic polyester resin and an aqueous or powder coating composition containing the same PPG INDUSTRIES OHIO, INC. (US) 2025-03-25 US claimed
WO-2024235829-A1 ACTINICALLY-CURABLE COMPOSITIONS HAVING HIGH DIMENSIONAL ACCURACY ARKEMA FRANCE (FR) 2024-11-21 WO claimed
US-12013523-B2 Immersion oils having long service life CARL ZEISS JENA GMBH (DE) 2024-06-18 US claimed
US-20240094519-A1 ACETALS OF TRICYCLODECANE ALCOHOLS AS IMMERSION LIQUID MEDIA CARL ZEISS JENA GMBH (DE) 2024-03-21 US claimed
EP-4097197-B1 TCD-ESTERS FOR LOW TEMPERATURE LIQUID APPLICATIONS OQ CHEMICALS GMBH (DE) 2024-03-20 EP claimed
US-11795410-B2 TCD-esters for low temperature liquid applications OQ CHEMICALS GMBH 2023-10-24 US claimed
US-20230063112-A1 TCD-Esters for Low Temperature Liquid Applications OQ CHEMICALS GMBH (DE) 2023-03-02 US claimed
EP-4097197-A1 TCD-ESTERS FOR LOW TEMPERATURE LIQUID APPLICATIONS OQ Chemicals GmbH (DE) 2022-12-07 EP claimed
CN-114945656-A TCD esters for low temperature lubricant applications OQ化学有限责任公司 2022-08-26 CN claimed
WO-2021152001-A1 TCD-ESTERS FOR LOW TEMPERATURE LIQUID APPLICATIONS OQ CHEMICALS GMBH (DE) 2021-08-05 WO claimed
US-4086285-A Tricyclo[6.2.1.02,6 ]undeca-2(6)-ene and process for hydride transfer reduction rearrangement of same KAO SOAP CO., LTD. (JA) 1978-04-25 US claimed
JP-55045638-A None JP disclosed
JP-55045640-A None JP disclosed
JP-52083357-A None JP disclosed
JP-S5545638-A EXO-5-HALOMETHYL-ENDO-2,3-TRIMETHYLENE NORBORNANE KAO CORP 1980-03-31 JP disclosed
JP-S5545640-A EXO-5-METHYL-ENDO-2,3-TRIMETHYLENE NORBORNANE KAO CORP 1980-03-31 JP disclosed
JP-S5283357-A SYNTHESIS OF 8-ENDO-HYDROXYMETHYL-ENDO-TRICYCLO(5.2.1.02,6) DECANE KAO CORP 1977-07-12 JP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12013523-B2 Immersion oils having long service life DGKI, CCNE2, CYCS MAPT 4048/4885CA12 1119/4885GMNN 3627/4885
US-20230063112-A1 TCD-Esters for Low Temperature Liquid Applications MLYCD, MSMO1, ACMSD MAPT 1095/4885CA12 1439/4885GMNN 3238/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.